Orange Book product · Generic (ANDA)
CARISOPRODOL
CARISOPRODOL
At a glance
Oct 28, 2014
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 28, 2014
11 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
CARISOPRODOL
Strength
350MG
Dosage form
TABLET
Route
ORAL
TE code
AA
Application
ANDA 205085
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CARISOPRODOL
- —SOMABrand (NDA)
NDA 011792 · MYLAN SPECIALITY LP
- —RELABrand (NDA)
NDA 012155 · SCHERING
- 2021CARISOPRODOLGeneric (ANDA)
ANDA 211789 · POINTVIEW HLDINGS
- 2017CARISOPRODOLGeneric (ANDA)
ANDA 207237 · MPP PHARMA
- 2016CARISOPRODOLGeneric (ANDA)
ANDA 040792 · AUROBINDO PHARMA
- 2015CARISOPRODOLGeneric (ANDA)
ANDA 205513 · STRIDES PHARMA
- 2015CARISOPRODOLGeneric (ANDA)
ANDA 205126 · HERITAGE
- 2014CARISOPRODOLGeneric (ANDA)
ANDA 090988 · NATCO
- 2014CARISOPRODOLGeneric (ANDA)
ANDA 203374 · SCIEGEN PHARMS
- 2008CARISOPRODOLGeneric (ANDA)
ANDA 040823 · INGENUS PHARMS LLC
- 2007CARISOPRODOLGeneric (ANDA)
ANDA 040755 · SUN PHARM INDS LTD
- 2005CARISOPRODOLGeneric (ANDA)
ANDA 040576 · ACCELRX LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
